The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer

Sudha S. Savant, Shruthi Sriramkumar, Heather O'Hagan

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.

Original languageEnglish (US)
Article number251
JournalCancers
Volume10
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Inflammation Mediators
Neoplasm Metastasis
Inflammation
Tumor Microenvironment
Ovulation
Epigenomics
Cell Division
Ovarian Neoplasms
Prostaglandins
Reactive Oxygen Species
Neoplasms
Intercellular Signaling Peptides and Proteins
Epithelial Cells
Cell Proliferation
Ovarian epithelial cancer
Cytokines

Keywords

  • Cytokines
  • Epithelial ovarian cancer
  • Growth factors
  • Inflammation
  • Reactive oxygen species

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. / Savant, Sudha S.; Sriramkumar, Shruthi; O'Hagan, Heather.

In: Cancers, Vol. 10, No. 8, 251, 01.08.2018.

Research output: Contribution to journalReview article

@article{c81c08ab5e39433ab6626ebc6690a426,
title = "The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer",
abstract = "Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.",
keywords = "Cytokines, Epithelial ovarian cancer, Growth factors, Inflammation, Reactive oxygen species",
author = "Savant, {Sudha S.} and Shruthi Sriramkumar and Heather O'Hagan",
year = "2018",
month = "8",
day = "1",
doi = "10.3390/cancers10080251",
language = "English (US)",
volume = "10",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer

AU - Savant, Sudha S.

AU - Sriramkumar, Shruthi

AU - O'Hagan, Heather

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.

AB - Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.

KW - Cytokines

KW - Epithelial ovarian cancer

KW - Growth factors

KW - Inflammation

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=85051128190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051128190&partnerID=8YFLogxK

U2 - 10.3390/cancers10080251

DO - 10.3390/cancers10080251

M3 - Review article

AN - SCOPUS:85051128190

VL - 10

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 8

M1 - 251

ER -